1,228
Views
4
CrossRef citations to date
0
Altmetric
Review

Ocular treatment of thyroid eye disease

, , , &
Pages 313-325 | Published online: 09 Jan 2014
 

Abstract

Thyroid eye disease is an autoimmune disease affecting ocular and orbital tissues. The inflammation may or may not parallel systemic thyroid conditions such as Graves’ disease. Disease manifestations result from tissue remodeling within the orbit. The abnormal stimulation of immune cells and orbital fibroblasts is probably involved. Our current understanding of the pathophysiology of the disease is limited and few rational therapies have been designed that target the underlying disease process. Treatment strategies vary depending on disease severity and activity. Recent small-scale studies have shown some promise with B-cell-depleting drugs such as rituximab, but this therapy requires further evaluation. The testing of new treatments is hindered by the lack of a reliable animal model of thyroid eye disease.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.